Astrana Health, Inc.
ASTH
$31.40
$0.501.62%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -13.15% | -72.25% | -87.16% | -58.79% | -39.76% |
| Total Other Revenue | 90.30% | 40.70% | 44.37% | 22.28% | 22.23% |
| Total Revenue | 88.43% | 37.49% | 39.65% | 19.90% | 20.00% |
| Cost of Revenue | 95.74% | 47.15% | 40.95% | 14.17% | 24.07% |
| Gross Profit | 29.50% | 0.95% | 32.76% | 54.57% | -5.13% |
| SG&A Expenses | 9.71% | 28.54% | 49.46% | 82.81% | 55.24% |
| Depreciation & Amortization | 65.77% | 68.73% | 75.16% | 18.73% | 20.65% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 86.18% | 45.68% | 42.04% | 18.85% | 26.73% |
| Operating Income | 118.60% | -27.27% | 11.24% | 34.71% | -130.76% |
| Income Before Tax | -305.09% | -29.47% | 1.29% | 23.67% | -91.16% |
| Income Tax Expenses | 477.80% | -22.02% | -28.40% | 3.19% | -91.02% |
| Earnings from Continuing Operations | -8,173.40% | -32.15% | 25.08% | 35.03% | 89.35% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -93.37% | 51.18% | 37.50% | -414.75% | 537.61% |
| Net Income | -156.26% | -27.04% | 45.57% | 12.97% | 431.44% |
| EBIT | 118.60% | -27.27% | 11.24% | 34.71% | -130.76% |
| EBITDA | 757.17% | -17.74% | 19.91% | 32.14% | -93.80% |
| EPS Basic | -157.69% | -28.78% | 42.11% | 11.27% | 402.33% |
| Normalized Basic EPS | -94.60% | -30.10% | 13.98% | -27.82% | 59.19% |
| EPS Diluted | -158.09% | -29.79% | 42.86% | 10.71% | 400.23% |
| Normalized Diluted EPS | -94.60% | -30.35% | 13.81% | -27.86% | 59.19% |
| Average Basic Shares Outstanding | -2.49% | 2.45% | 2.44% | 1.51% | 9.67% |
| Average Diluted Shares Outstanding | -2.49% | 2.78% | 2.57% | 1.59% | 9.67% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | 14.33% |